IMM 5.80% 32.5¢ immutep limited

Ann: Encouraging Phase II TACTI-002 data reported at SITC 2020, page-33

  1. 825 Posts.
    lightbulb Created with Sketch. 1146
    This is LAG525 arm does not look pretty.
    Not bad enough to sentence LAG525 to end though. They say they will do more molecular profiling and maybe subgroup analyses?
    Don't think this LAg525 is going anywhere in the near term.

    Now focus on AIPAC, TACTI002 and the EAT-COVID studies.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.